Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04727151
Title TAC T-cells for the Treatment of HER2-positive Solid Tumors (TACTIC-2)
Acronym TACTIC-2
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Triumvira Immunologics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Lurie Cancer Center - Northwestern University Chicago Illinois 60611 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey Newark New Jersey 08901 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Cincinnati Cancer Center Cincinnati Ohio 45267 United States Details
Sidney Kimmel Cancer Center - Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2C1 Canada Details
Centre Hospitalier de l'Université de Montréal/Montreal Hospital University Center (CHUM) Montréal Quebec H2X 0A9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field